Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients.
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:
